Details for: ATHENA-ONDANSETRON ODT
Company: ATHENA PHARMACEUTIQUES SAS
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02444674 | ATHENA-ONDANSETRON ODT | ONDANSETRON | 4 MG | TABLET (ORALLY DISINTEGRATING) | ORAL |
| 02444682 | ATHENA-ONDANSETRON ODT | ONDANSETRON | 8 MG | TABLET (ORALLY DISINTEGRATING) | ORAL |
Summary Reports
Summary Safety Review - ZOFRAN (ondansetron) - Assessing the Potential Harm to the Fetus
Summary Safety Review - Serotonin blocking drugs (serotonin antagonists) ALOXI® (palonosetron), ANZEMET® (dolasetron), KYTRIL® (granisetron) and generics, and ZOFRAN® (ondansetron) and generics - Serotonin Syndrome
Summary Safety Review - Serotonin blocking drugs (serotonin antagonists) ALOXI® (palonosetron), ANZEMET® (dolasetron), KYTRIL® (granisetron) and generics, and ZOFRAN® (ondansetron) and generics - Serotonin Syndrome
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.